How much revenue did Fresenius Medical Care generate this year?
Fresenius Medical Care has achieved a revenue of 19.95 B EUR this year.
In 2024, Fresenius Medical Care's sales reached 19.95 B EUR, a 2.56% difference from the 19.45 B EUR sales recorded in the previous year.
YEAR | REVENUE (undefined EUR) | GROSS MARGIN (%) |
---|---|---|
2030e | 26.17 | 18,82 |
2029e | 25.89 | 19,03 |
2028e | 25.01 | 19,69 |
2027e | 23.74 | 20,74 |
2026e | 21.61 | 22,80 |
2025e | 20.74 | 23,75 |
2024e | 19.95 | 24,68 |
2023 | 19.45 | 25,32 |
2022 | 19.4 | 25,23 |
2021 | 17.62 | 27,09 |
2020 | 17.86 | 31,01 |
2019 | 17.48 | 30,87 |
2018 | 16.55 | 31,15 |
2017 | 17.78 | 33,84 |
2016 | 16.57 | 33,89 |
2015 | 15.45 | 33,50 |
2014 | 12.14 | 32,85 |
2013 | 11.22 | 33,71 |
2012 | 10.96 | 34,65 |
2011 | 9.19 | 35,38 |
2010 | 9.09 | 34,34 |
2009 | 8.07 | 34,11 |
2008 | 7.23 | 34,32 |
2007 | 7.13 | 34,62 |
2006 | 6.77 | 33,86 |
2005 | 5.45 | 34,44 |
2004 | 5.01 | 33,49 |
In the annual report of the Fresenius Medical Care share (DE0005785802, 578580, FME.DE), it breaks down its revenues into 4 segments: 1. North America, 2. EMEA, 3. Asia-Pacific, 4. Latin America. The Fresenius Medical Care stock (WKN: 578580, ISIN: DE0005785802, Ticker Symbol: FME.DE) is a leading investment for investors interested in participating in the Health Care sector.
The sales figures of Fresenius Medical Care originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Analyzing Fresenius Medical Care’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Investors often scrutinize Fresenius Medical Care's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Increases in Fresenius Medical Care’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Fresenius Medical Care has achieved a revenue of 19.95 B EUR this year.
The revenue of Fresenius Medical Care has increased by 2.56% increased compared to the previous year.
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
The revenue of Fresenius Medical Care is influenced by various factors, including the demand for its products and services, market conditions, and prices.
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
The revenue of Fresenius Medical Care is an important indicator of financial performance and attractiveness for investors.
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
Over the past 12 months, Fresenius Medical Care paid a dividend of 1.12 EUR . This corresponds to a dividend yield of about 2.87 %. For the coming 12 months, Fresenius Medical Care is expected to pay a dividend of 1.14 EUR.
The current dividend yield of Fresenius Medical Care is 2.87 %.
Fresenius Medical Care pays a quarterly dividend. This is distributed in the months of September, June, June, June.
Fresenius Medical Care paid dividends every year for the past 33 years.
For the upcoming 12 months, dividends amounting to 1.14 EUR are expected. This corresponds to a dividend yield of 2.93 %.
Fresenius Medical Care is assigned to the 'Health' sector.
To receive the latest dividend of Fresenius Medical Care from 5/21/2024 amounting to 1.19 EUR, you needed to have the stock in your portfolio before the ex-date on 5/17/2024.
The last dividend was paid out on 5/21/2024.
In the year 2023, Fresenius Medical Care distributed 1.35 EUR as dividends.
The dividends of Fresenius Medical Care are distributed in EUR.
The Fresenius Medical Care stock can be added to a savings plan with the following providers: Trade Republic, ING, Scalable Capital and Consorsbank
Our stock analysis for Fresenius Medical Care Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Fresenius Medical Care Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.